"Now that pharmacological treatments for Alzheimer's Disease are available, clinicians, purchasers of services, pharmacists, health economists, sufferers and carers all need to know the outcomes of treatment and how these can best be measured. This book considers outcome measures relevant for Alzheimer's disease, identifies suitable assessment tools and considers the relative merits of each of these. In addition to domains by regulatory bodies (cognition, global functioning and activities of daily living), there are original reviews of new and important aspects of the various outcomes including neuropsychiatric features, quality of life measures and caregiver burden." "With each section written by an internationally respected opinion leader, this authoritative guide provides an important addition to the literature in this area and will be of real assistance to hospital clinicians, interested general practitioners and others working in the field."--BOOK JACKET.